Updated Aug. 7, 2017 at 2:11 p.m.

Premium Lock Tidewater Equity cashes in on pharma startup's $80M sale

Published: 2017-08-07 08:11:00
Updated: 2017-08-07 14:11:26

Merrette Moore Merrette Moore

Tidewater Equity Ventures cashes in on an investment in a Pennsylvania pharmaceutical startup that is being acquired by Mallinckrodt Pharmaceuticals in a deal that could be worth as much as $425 million. Plus: Why Mallinckrodt says the deal happened....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders